Literature DB >> 7137829

An assessment of ultrasound scanning in the recognition of colorectal liver metastases.

G Lamb, I Taylor.   

Abstract

The preoperative detection of visible liver metastases in patients with colorectal cancer is important in determining a rational treatment policy. The accuracy of haptic ultrasound scanning was assessed in 100 patients with primary colorectal cancer. Each patient had a 99mTc-sulphur colloid scan, ultrasound scan, and liver function test. All patients came to laparotomy and the liver was carefully palpated. With very few exceptions the combination of isotope and ultrasound scanning gave accurate information on the state of the liver in all patients in this series. Alkaline phosphatase was the only enzyme whose serum activity was consistently elevated in the presence of liver metastases. Ultrasound scanning of the liver is a simple, safe, accurate, and non-invasive method for preoperative assessment of the state of the liver in patients with primary colorectal cancer.

Entities:  

Mesh:

Year:  1982        PMID: 7137829      PMCID: PMC2494097     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  8 in total

1.  Factors influencing survival in patients with untreated hepatic metastases.

Authors:  B M Jaffe; W L Donegan; F Watson; J S Spratt
Journal:  Surg Gynecol Obstet       Date:  1968-07

2.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

3.  The value of liver scan in the follow-up study of patients with adenocarcinoma of the colon and rectum.

Authors:  B J Cedermark; S S Schultz; S Bakshi; K L Parthasarathy; A Mittelman; J T Evans
Journal:  Surg Gynecol Obstet       Date:  1977-05

4.  Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes.

Authors:  I M Ariel; G Padula
Journal:  J Surg Oncol       Date:  1978       Impact factor: 3.454

5.  Ultrasonographic evaluation of chemotherapeutic response in hepatic metastases.

Authors:  M E Bernardino; B Green
Journal:  Radiology       Date:  1979-11       Impact factor: 11.105

6.  Gray scale ultrasound evaluation of hepatic neoplasms: patterns and correlations.

Authors:  B Green; R L Bree; H M Goldstein; C Stanley
Journal:  Radiology       Date:  1977-07       Impact factor: 11.105

7.  Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil.

Authors:  F J Ansfield; G Ramirez; H L Davis; G W Wirtanen; R O Johnson; G T Bryan; F B Manalo; E C Borden; T E Davis; M Esmili
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

8.  Ultrasound and hepatic metastases.

Authors:  F R Vicary; I Shirley
Journal:  Br J Radiol       Date:  1978-08       Impact factor: 3.039

  8 in total
  3 in total

1.  Focal fatty infiltration of the liver mimicking metastatic disease.

Authors:  Y Bashir
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

2.  Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Authors:  R H Taylor; J M Gilbert; M G Evans; H G Lane; P G Cassell
Journal:  Clin Exp Metastasis       Date:  1984 Oct-Dec       Impact factor: 5.150

3.  Oral urea in the treatment of secondary tumours in the liver.

Authors:  P I Clark; M L Slevin; J A Webb; R J Osborne; S Jones; P F Wrigley
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.